Abstract
Objective To explore the associations between childhood infections and subsequent diagnoses of autism spectrum disorder (ASD), intellectual disability (ID) and their co-occurrence.
Methods The association between specialized care for any infection, defined by ICD-codes and later ASD or ID was investigated in a register-based cohort of 556,732 individuals born 1987-2010, resident in Stockholm County, followed from birth to their 18th birthday or December 31, 2016. We considered as potential confounders children’s characteristics, family socioeconomic factors, obstetric complications, and parental histories of both treatment for infection and psychiatric disorders in survival analyses with extended Cox regression models. Residual confounding by shared familial factors was addressed in sibling analyses using within-strata estimation in Cox regression models. Sensitivity analyses with exclusion of congenital causes of ASD/ID and documented risk for infections were also performed.
Results Crude estimates indicated that infections during childhood were associated with later ASD and ID with largest risks observed for diagnoses involving ID. Inclusion of covariates, exclusion of congenital causes of ASD/ID from the population and sibling comparisons highlighted the potential for confounding by both heritable and non-heritable factors, though risks remained in all adjusted models. In adjusted sibling comparisons, excluding congenital causes, infections were associated with later ‘ASD without ID’ (HR 1.24, 95%CI 1.15-1.33), ‘ASD with ID’ (1.57, 1.35-1.82) and ‘ID without ASD’ (2.01, 1.76-2.28). Risks associated with infections varied by age at exposure and by age at diagnosis of ASD/ID.
Conclusions Infections during childhood cannot be excluded in the etiology of ASD, particularly ASD with co-occurring ID.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was generously supported by the Stanley Medical Research Institute (NV-002, HK) and the Swedish Research Council, grant numbers 2018-02907 (HK), 2016-01477, 2012-2264 and 523-2010-1052 (CD)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Stockholm Regional Ethics Committee, #2010/1185-31/5.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Previous presentations: None
E-mail addresses: Hugo Sjöqvist (hugo.sjoqvist{at}ki.se), Martin Brynge (m.brynge{at}ki.se), Reneé Gardner (renee.gardner{at}ki.se), Christina Dalman (christina.dalman{at}ki.se)
Disclosure: None of the authors have any financial relationships with commercial interests to disclose.
Data Availability
The Swedish health and population register data used in this study are available from Statistics Sweden and the Swedish National Board of Health and Welfare. The authors are not allowed to distribute the data according to the ethical approval for this study and the agreements with Statistics Sweden and the Swedish National Board of Health and Welfare.
